Edyta GLOGOWSKA | Cell Metabolism | Best Researcher Award

Posted on by Neuroscientists

Dr. Edyta Glogowska | Cell Metabolism | Best Researcher Award

Dr.  Edyta Glogowska, CNRS-IPMC-UniCA,  France.

Dr. Edyta Glogowska is a passionate and accomplished biomedical researcher with a strong academic background in biotechnology and life sciences. From her early beginnings in dental engineering to earning a PhD in red blood cell physiology from the University Pierre and Marie Curie, her academic journey reflects a deep commitment to advancing human health through science. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) highlights her expertise in cell physiology, electrophysiology, and molecular biology, with a special focus on macrophage Piezo1 channels and their role in atherosclerosis. She is a skilled communicator and team collaborator, recognized for her academic excellence and contributions to hematology and immunopathology.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Edyta Glogowska’s journey into the world of life sciences began with a strong foundation in biotechnology and medical sciences. She earned her Master of Engineering in Biotechnology Processing from Wroclaw University of Science and Technology, where she graduated with highest honors. Even earlier, she had already laid a unique cornerstone for her biomedical interests through specialized training as a Dental Engineer at the Marie Curie Medical Vocational School. Her pursuit of deeper scientific knowledge led her to France, where she undertook her PhD in Biological and Life Sciences at the University Pierre and Marie Curie, Paris VI. Conducted at the prestigious Station Biologique in Roscoff, her doctoral research focused on red blood cell physiology and was awarded with the highest honors—a testament to her early dedication and scientific promise.

🔬 Professional Endeavors

Dr. Glogowska’s professional career has been marked by a steadfast commitment to cell and molecular biology, electrophysiology, and the biochemistry of proteins. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) in Sophia Antipolis (2021–2024) showcases her hands-on expertise with mice experimentation and patch-clamp techniques, placing her at the cutting edge of biomedical research. Working under the guidance of Dr. Eric Honoré, she explored the role of macrophage Piezo1 channels regulated by lipids, a study with far-reaching implications in understanding and potentially treating atherosclerosis.

🧬 Contributions and Research Focus

Throughout her academic and postdoctoral years, Dr. Glogowska has focused her research on the physiology and pathophysiology of cells, particularly red blood cells and immune cells like macrophages. Her interest lies in understanding how cellular mechanisms contribute to broader medical conditions, such as cardiovascular diseases. By integrating electrophysiology with molecular biology, she brings a comprehensive approach to biomedical questions, bridging the gap between basic research and therapeutic application. Her work on Piezo1 not only contributes to our understanding of mechanotransduction in macrophages but also holds promise for future translational research.

🏅 Accolades and Recognition

Dr. Glogowska’s scholarly excellence has been consistently recognized. She graduated with highest honors both for her Master’s and PhD degrees, a rare academic distinction that underscores her dedication and intellectual rigor. She has also been an active member of the French Society of Hematology, aligning herself with leading experts in her field and staying abreast of the latest developments in blood cell research. These accolades reflect her respected standing within the scientific community.

🌍 Impact and Influence

Beyond technical expertise, Dr. Glogowska is praised for her team coordination and communication skills, qualities that have enabled her to contribute meaningfully to collaborative research environments. Her scientific efforts in understanding lipid–ion channel interactions in macrophages directly influence the broader field of cardiovascular immunology. By elucidating the role of Piezo1 channels in inflammatory processes, her research provides foundational knowledge that can inspire novel pharmacological interventions.

🔎 Legacy and Future Contributions

Dr. Glogowska continues to strive toward a future where her research leads to medical breakthroughs in inflammation and cardiovascular disease. She is particularly interested in translational science, where laboratory discoveries transition into clinical applications. Her strong background in biotechnology, dentistry, and molecular biology uniquely equips her to explore cross-disciplinary challenges in human health. As she advances, she aims to bridge research with clinical solutions, contributing to a legacy of innovation in life sciences.

Publication

Title: Potentiation of macrophage Piezo1 by atherogenic 7-ketocholesterol
Authors: Edyta Glogowska, Gregor P. Jose, Ana Rita Dias Araújo, Laurent Yvan-Charvet, Éric R. Honoré
Year: 2025

Title: Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development
Authors: Fenja Knoepp, Shariq Abid, Amal Houssaïni, Éric R. Honoré, Serge Adnot
Year: 2025

Title: Pharmacological activation of PIEZO1 in human red blood cells prevents Plasmodium falciparum invasion
Authors: Rakhee Lohia, Benoit Allegrini, Laurence Berry, Éric R. Honoré, Kai Wengelnik
Year: 2023

Title: A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes
Authors: Candela Diaz-Canestro, Jiarui Chen, Yan Liu, Michael Andrew Tse, Aimin Xu
Year: 2023

Title: Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects
Authors: Kang Chen, Lai Yee Cheong, Yuan Gao, Hannah Xiaoyan Hui, Aimin Xu
Year: 2022

Title: Author Correction: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: (Correction Published) — Likely 2021 or 2022

Title: Piezo1 and Piezo2 foster mechanical gating of K2P channels
Authors: Edyta Glogowska, Malika Arhatte, Franck C. Chatelain, Amanda Jane Patel, Éric R. Honoré
Year: 2021

Title: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: 2020

Title: Piezo Ion Channels in Cardiovascular Mechanobiology
Authors: Dominique Douguet, Amanda Jane Patel, Aimin Xu, Paul Michel Vanhoutte, Éric R. Honoré
Year: (Not explicitly stated, likely ~2020 based on context)

Title: TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells
Authors: Malika Arhatte, Gihan S. Gunaratne, Charbel El Boustany, Éric R. Honoré, Amanda Jane Patel
Year: 2019

 

 

✅ Conclusion

Driven by curiosity and guided by precision, Dr. Glogowska continues to make meaningful strides in biomedical research. Her work stands at the intersection of basic science and medical application, with the potential to influence future therapeutic strategies for cardiovascular and inflammatory diseases. With her versatile skill set and visionary approach, she is well-positioned to leave a lasting impact on the scientific and medical communities. As she moves forward, Dr. Glogowska aspires to further bridge laboratory discoveries with clinical innovations, fostering a legacy of scientific excellence and translational breakthroughs.

 

Paolo Grumati | Cell Biology | Best Researcher Award

Posted on by Neuroscientists

Prof. Paolo Grumati | Cell Biology | Best Researcher Award

Prof. Paolo Grumati,  TIGEM, Italy.

Dr. Paolo Grumati is a prominent researcher and academic with a focus on molecular biology, particularly the study of autophagy and its role in diseases such as muscular dystrophies and neurodegenerative disorders. His academic journey, beginning with a Master’s and Ph.D. from the University of Padova, laid the foundation for his pioneering work in the molecular mechanisms underlying disease pathogenesis. Dr. Grumati’s professional endeavors have included roles at esteemed institutions like Johann Wolfgang Goethe University and the Telethon Institute of Genetics and Medicine (TIGEM), where he leads groundbreaking research in selective autophagy. His work, which integrates advanced techniques like CRISPR/Cas9, has earned him widespread recognition and numerous accolades, including positions as Associate Professor at the University of Naples. His research has had a significant impact on the scientific community, particularly in the areas of cellular maintenance and therapeutic development.

Profile

Scopus

 

Early Academic Pursuits 🎓


Paolo Grumati’s academic journey began at the University of Padova in Italy, where he pursued a Master’s Degree in Medical Biotechnologies, graduating in 2005. His deep curiosity in the molecular underpinnings of human biology led him to continue his studies with a Ph.D. in Genetic and Molecular Biology, completed between 2006 and 2009. During his Ph.D., he focused on the genetic mechanisms that contribute to various diseases, a pursuit that sparked his lasting interest in molecular biology and disease pathogenesis. His early academic training laid a strong foundation for his future research in the biochemistry of diseases, especially those that affect muscle function and cellular processes.

Professional Endeavors 💼


Dr. Grumati’s professional career has been marked by an impressive trajectory across prestigious institutions. After completing his postdoctoral work on the pathogenesis of muscular dystrophies at the University of Padova, he moved to Germany, where he took a position at the Institute of Biochemistry II at Johann Wolfgang Goethe University. There, between 2013 and 2018, he specialized in the biochemistry and molecular biology of autophagy, a crucial cellular process related to health and disease. His expertise in autophagy became a defining element of his career, and in 2019, he was appointed as the Assistant Investigator and Head of the Mass Spectrometry Core at the Telethon Institute of Genetics and Medicine (TIGEM), where he leads innovative research into the molecular mechanisms of selective autophagy. Throughout these roles, Dr. Grumati has built a reputation for integrating advanced techniques like CRISPR/Cas9 into his work, influencing the field of genetic research.

Contributions and Research Focus 🔬


Dr. Grumati’s research focus has consistently revolved around the intricate molecular processes that govern cellular maintenance and disease, particularly through the lens of autophagy. Since becoming a principal investigator in 2019, his work at TIGEM has concentrated on understanding the molecular mechanisms of selective autophagy, which plays a pivotal role in cellular health and disease. He has pioneered methods to study and manipulate these processes, contributing significantly to the understanding of diseases such as muscular dystrophies and neurodegenerative disorders. His research not only delves into the underlying biology of these conditions but also seeks to identify therapeutic targets that could help manage or even cure these diseases.

Accolades and Recognition 🏆


Dr. Grumati has received widespread recognition for his work in molecular biology and biochemistry. His contributions to the field of autophagy and muscle biology have been honored with leadership roles in prominent research teams, including his time as Team Leader of the Frankfurt CRISPR/Cas9 Screening Center. His excellence in research has earned him a faculty position as Assistant Professor at the University of Naples “Federico II” and an eventual promotion to Associate Professor in 2024. His expertise in mass spectrometry and molecular biology has also made him a sought-after figure in the scientific community, where he is frequently invited to collaborate on interdisciplinary research projects.

Impact and Influence 🌍


Dr. Grumati’s research has had a lasting impact on the scientific community, particularly in the fields of autophagy and muscular dystrophies. His work has influenced both theoretical and applied aspects of molecular biology, from basic research to potential therapeutic interventions. Through his leadership at TIGEM and his involvement in international collaborations, Dr. Grumati has helped to shape the direction of research into autophagy-related diseases. His studies have not only provided insights into the cellular mechanisms at play in these diseases but also paved the way for future therapeutic strategies. He is seen as a key figure in the advancement of precision medicine and molecular therapeutics.

Legacy and Future Contributions 🔮

As Dr. Grumati moves forward in his career, his contributions to the fields of genetics and molecular biology are expected to have a profound and lasting influence. His current work, focusing on selective autophagy, holds promise for the development of novel treatments for diseases that currently have limited therapeutic options. His legacy will likely include innovations in understanding cellular degradation processes and their application to genetic disorders and other diseases. The future of Dr. Grumati’s research will continue to explore the molecular intricacies of human health, offering the potential for breakthroughs in regenerative medicine and disease treatment.

Teaching and Mentorship 👨‍🏫


Beyond his research, Dr. Grumati has made a significant impact through his academic roles at the University of Naples. As an Associate Professor, he plays a key role in shaping the next generation of molecular biologists. His teaching focuses on imparting knowledge in genetics, biochemistry, and molecular biology, with an emphasis on practical research applications. His mentorship has helped guide many students and early-career researchers, who have gone on to make their own contributions to the field. Dr. Grumati’s ability to translate complex scientific concepts into accessible lessons ensures that his influence extends far beyond his own research.

Publication

  • Title: Cortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling
    Authors: M. de Risi, D. Cavezza, G. Torromino, P. Grumati, E. de Leonibus
    Year: 2025

 

  • Title: Two FAM134B isoforms differentially regulate ER dynamics during myogenesis
    Authors: V. Buonomo, K.O. Lohachova, A. Reggio, R.M. Bhaskara, P. Grumati
    Year: 2025

 

  • Title: Ezrin defines TSC complex activation at endosomal compartments through EGFR-AKT signaling
    Authors: G. Giamundo, D. Intartaglia, E. del Prete, R. De Cegli, I. Conte
    Year: 2025

 

  • Title: 3D Rotary Wet-Spinning (RoWS) Biofabrication Directly Affects Proteomic Signature and Myogenic Maturation in Muscle Pericyte–Derived Human Myo-Substitute
    Authors: A. Reggio, C. Fuoco, F. de Paolis, M. Costantini, C. Gargioli
    Year: 2025

 

  • Title: Cross-Linking Mass Spectrometry to Capture Protein Network Dynamics of Cell Membranome
    Authors: L. Santorelli, M. Costanzo, S. Petrosino, M. Ruoppolo, P. Grumati
    Year: 2025

 

  • Title: Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces
    Authors: P. Romani, G. Benedetti, M. Cusan, G. Martello, S. Dupont
    Year: 2024

 

Conclusion


Dr. Paolo Grumati’s career exemplifies the integration of scientific inquiry with practical application, as his research continues to shed light on crucial molecular processes that affect human health. His contributions to the understanding of autophagy have opened new avenues for potential therapeutic strategies in treating genetic disorders and other diseases. As he continues to lead research at TIGEM and teach at the University of Naples, Dr. Grumati’s legacy is set to influence the fields of molecular biology, genetics, and medicine for years to come. His work remains pivotal in advancing both the theoretical understanding of disease mechanisms and the development of new therapeutic approaches, positioning him as a key figure in modern biomedical research.

Noha Ibrahim | Neuroplacentology | Best Researcher Award

Posted on by Neuroscientists

Dr. Noha Ibrahim | Neuroplacentology | Best Researcher Award

Dr. Noha Ibrahim, HSE, Ireland.

Noha Ibrahim’s journey from her early academic excellence to becoming a leading psychiatrist reflects her dedication to medicine and mental health. Her extensive experience across multiple psychiatric subspecialties, coupled with her commitment to research and education, has made a significant impact in the field. Her expertise in neuropsychiatry and autism spectrum disorders, along with her contributions to psychotherapy and mental health advocacy, highlights her influential role in psychiatric care.

Profile

Orcid

✨ Early Academic Pursuits ✨

Noha Ibrahim’s academic journey began at Khartoum International Preparatory School (KIPS), Sudan, where she laid the foundation for her future in medicine. Demonstrating exceptional promise, she pursued her undergraduate studies at the National Ribat University in Khartoum, earning her Medicine and Surgery Bachelor’s Degree in 2008. During her studies, her dedication to research and academic excellence was recognized when she was awarded the Best National Medical Student Research accolade in 2007. This early recognition highlighted her potential and set the stage for an impactful career in psychiatry.

🏥 Professional Endeavors 🏥

With over 11 years of experience in psychiatry, Noha Ibrahim has contributed significantly to multiple subspecialties, including General Adult Psychiatry, Liaison Psychiatry, Addiction Psychiatry, Child and Adolescent Mental Health Services (CAMHS), Rehabilitation, Intellectual Disability, Neuropsychiatry, and Adult ADHD. Her rigorous training led her to achieve the Certificate of Satisfactory Completion of Specialist Training (CSCST) in General Adult Psychiatry with a focus on academic neuropsychiatry in January 2024 from the College of Psychiatry in Ireland (COPI). Noha’s professional journey reflects her unwavering commitment to advancing mental health care through clinical expertise and continuous learning.

📚 Contributions and Research Focus 📚

Throughout her career, Noha Ibrahim has remained actively engaged in research and clinical education. Her passion for academia led her to complete a Postgraduate Diploma in Health Sciences in 2022, followed by a Master’s in Clinical Education at the University of Galway in 2023. She has been extensively trained in Autism Diagnostic Observation Schedule (ADOS) since 2020 and Autism Clinical Interview for Adults (ACIA) in 2024. Noha’s research interests focus on neuropsychiatry, autism spectrum disorders, and the application of structured therapeutic models in clinical practice, ensuring that her contributions extend beyond patient care into shaping the future of psychiatric education and training.

🏆 Accolades and Recognition 🏆

Recognized for her excellence in both clinical and academic psychiatry, Noha Ibrahim has achieved multiple prestigious memberships and registrations. She has been a Member of the College of Psychiatrists of Ireland (MCPsychI) since 2020, an active member of the Irish Medical Council since 2013, and has maintained her Sudanese Medical Council registration since 2008. Her research excellence was acknowledged as early as 2007 when she was honored as the Best National Medical Student Researcher, an award that emphasized her dedication to advancing medical knowledge.

🧠 Impact and Influence 🧠

Beyond her clinical practice, Noha Ibrahim has played an instrumental role in advancing mental health awareness and education. She has provided psychotherapy using Cognitive Analytical Therapy (CAT) and Cognitive Behavioral Therapy (CBT) to patients with complex psychiatric needs. Additionally, her commitment to community mental health was evident when she facilitated Deciders Skills courses for teenagers in CAMHS, Co. Clare, in 2016, equipping young individuals with essential coping strategies. Her dedication to patient-centered care and education has made a lasting impact on both her colleagues and the patients she serves.

📝 Legacy and Future Contributions 📝

As a distinguished professional in the field of psychiatry, Noha Ibrahim continues to shape the future of mental health services through her expertise and research. With her extensive experience in neuropsychiatry and autism spectrum disorders, she aims to further develop specialized diagnostic and therapeutic approaches that can enhance patient care. Her contributions to psychiatric education and training will leave a lasting legacy, inspiring future generations of mental health professionals. With her dual Sudanese-Irish background, Noha represents a bridge between diverse medical communities, fostering collaboration and innovation in the field of psychiatry.

 

Publication

Title: Examining the association between placental malperfusion assessed by histopathological examination and child and adolescent neurodevelopment: a systematic review
Author(s): Noha Ibrahim, Sydni A. Weissgold, Lucy Brink, Ibtihal Mahgoub, Benjamin Richard Carter, Vaheshta Sethna, Hein Odendaal
Year: 2025

 

💪 Conclusion 💪

Through years of dedication, clinical expertise, and research, Noha Ibrahim has established herself as a highly respected psychiatrist and educator. Her impact on mental health care, particularly in neuropsychiatry, is profound, and her future contributions will continue to shape the landscape of psychiatric education and patient care. With her unwavering commitment to innovation and compassionate care, she remains a driving force in advancing the field of psychiatry for years to come.

 

Lucas Lopes | Medicina | Best Researcher Award

Posted on by Neuroscientists

Mr. Lucas Lopes | Medicina | Best Researcher Award

Mr. Lucas Lopes, Universidade de São Paulo, Faculdade de Medicina de Bauru,  Brazil.

Lucas Casagrande Passoni Lopes has made significant strides in medical research, academic publishing, and global scientific collaboration. His expertise in pediatric medicine, endocrinology, and healthcare disparities has been widely recognized through his editorial leadership, peer-review contributions, and multilingual engagements. His published works address critical healthcare issues, further cementing his influence in the medical community.

Profile

Orcid

🎓 Early Academic Pursuits

Lucas Casagrande Passoni Lopes embarked on his academic journey with an unwavering passion for medicine, enrolling in the prestigious Faculdade de Medicina de Bauru at the Universidade de São Paulo, Brazil. His commitment to excellence and keen interest in pediatric and clinical research set the foundation for his future endeavors. Throughout his academic years, he demonstrated exceptional dedication, immersing himself in scientific studies and medical advancements, laying the groundwork for a promising career in healthcare and medical research.

👩‍🎓 Professional Endeavors

Beyond his medical studies, Lucas took on significant roles in the academic publishing landscape. As the In-Chief Editor of Advances in Modern Paediatrics Journal, he has played a pivotal role in shaping pediatric research dissemination. His editorial contributions extend to renowned medical journals, including Journal of Anaesthesia and Global Open Share Publishing, Clinics of Neurology, Annals of Pediatrics and Neonatal Care, and the European Journal of Cancer. Through his editorial expertise, he has facilitated the publication of groundbreaking research, furthering advancements in multiple medical disciplines.

🔬 Contributions and Research Focus

Lucas has established himself as a prolific researcher, focusing on pediatric medicine, endocrinology, and public health concerns. His notable studies include an in-depth analysis of treatments for dysmenorrhea in adolescents, published in Contemporânea – Revista de Ética e Filosofia Política, and a groundbreaking study on the underreporting of diabetes mellitus as a cause of death over 40 years in Bauru, published in Archives of Endocrinology and Metabolism. His work sheds light on critical gaps in healthcare reporting and patient management, making substantial contributions to medical literature and clinical practice.

🏆 Accolades and Recognition

Lucas’ dedication to medical research has earned him esteemed recognition within the scientific community. As an invited reviewer for numerous high-impact journals, including Current Pediatric Reviews, World Journal of Clinical Cases, International Journal of Clinical and Experimental Medical Sciences, World Journal of Gastroenterology, and Frontiers in Medicine, he has been entrusted with evaluating and shaping contemporary medical research. His expertise is widely acknowledged, with his insights influencing the peer-review process across various fields of medicine.

📚 Impact and Influence

Lucas’ influence extends far beyond his research and editorial roles. His multilingual proficiency in Portuguese, English, French, Italian, Spanish, and German allows him to engage with diverse international scientific communities, fostering cross-border collaborations. His involvement in global medical discourse ensures that cutting-edge research reaches a broader audience, ultimately contributing to the improvement of healthcare systems worldwide. His mentorship and editorial leadership have guided emerging researchers, amplifying the impact of his contributions to medical academia.

🌟 Legacy and Future Contributions

With a strong foundation in medical research and editorial expertise, Lucas continues to shape the future of pediatric and clinical medicine. His ongoing commitment to identifying healthcare disparities, advancing treatment methodologies, and supporting evidence-based medical practices positions him as a key figure in modern medical research. As he forges ahead, his contributions promise to enhance patient care, influence policy reforms, and inspire future generations of medical professionals. His legacy in scientific inquiry and knowledge dissemination will undoubtedly leave a lasting mark on the field of medicine.

 

publication

  • Title: Association between exanthematous diseases and earlier age at Type 1 diabetes diagnosis
    Authors: Lucas C.P. Lopes, Lenita Zajdenverg, Rodrigo L.M. Martins, Gabriel Araujo Medeiros, Marina D. Louro, João V.M. Lanzarin, Carlos A. Negrato
    Year: 2025

 

  • Title: Mortality trends from all causes and diabetes mellitus according to sex between 1998 and 2021
    Authors: Carlos Antonio Negrato, Gabriel Araújo Medeiros, Giordano Bruno Duarte de Souza, Lucas Casagrande Passoni Lopes
    Year: 2024

 

  • Title: Relationship between early age at menarche, older age at menopause and subtypes of breast cancer: a scoping review
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Igor José Nogueira Gualberto, Thales Baptista Gut, Rafael Vasconcelos Silva Ferrazini, Carlos Antonio Negrato
    Year: 2024

 

  • Title: Association between perinatal and obstetric factors and early age at diagnosis of type 1 diabetes mellitus: a cohort study
    Authors: Carlos A. Negrato, Rodrigo L. de M. Martins, Marina D. Louro, Gabriel A. Medeiros, João V.M. Lanzarin, Lenita Zajdenverg, Lucas C.P. Lopes
    Year: 2024

 

  • Title: Underreporting of diabetes mellitus as the cause of death in Bauru, State of São Paulo, Brazil over 40 years: a documental study
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Mauro Wieczorek, Marina dos Santos de Carvalho Pinto, Carlos Antonio Negrato
    Year: 2024

 

🎉 Conclusion

As a dedicated researcher, editor, and medical professional, Lucas Passoni continues to push the boundaries of medical knowledge and patient care. His contributions have not only enriched scientific literature but have also fostered meaningful discussions on global healthcare improvements. With his unwavering commitment to excellence, Lucas is poised to leave a lasting legacy in the field of medicine, inspiring future generations of researchers and practitioners alike.

 

 

Zewen Cheng | Clinical Medicine | Young Scientist Award

Posted on by Neuroscientists

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,  China.

Zewen Cheng’s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

 

🎓 Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

🏥 Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

🔬 Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

🏆 Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

💪 Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

🌟 Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

 

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

 

🏆 Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.

 

 

Shahar Shelly | Epidemiology | Best Researcher Award

Posted on by Neuroscientists

Dr. Shahar Shelly | Epidemiology | Best Researcher Award

Dr. Shahar Shelly,  Rambam Medical Center, Israel.

Dr. Shahar Shelly, MD, is a globally recognized neurologist and researcher specializing in neuroimmunology and neuromuscular disorders. With academic roles across Rambam Medical Center, Technion Institute, and the Mayo Clinic, Dr. Shelly has driven advancements in clinical diagnostics, treatment strategies, and disease understanding.

 

profile

Scholor

🎓 Education

University Medical School of Hungary, Debrecen – Summa Cum Laude (01/2005–01/2012). Shamir Medical Center, Zerifin, Israel – Internship (Cum Laude) (01/2012–01/2013). Sheba Medical Center – Residency, Neurology Department (01/2013–01/2017). Mayo Clinic, Rochester, MN – Neuroimmunology Fellowship (04/2018–07/2019). Neuromuscular Disorders, Muscle Fellowship – Mayo Clinic (07/2019–07/2020) Neuromuscular Disorders, Nerve Fellowship – Mayo Clinic (07/2020–07/2021).

📜 Certifications

Israeli Neurology Board Certification (2018). Educational Commission for Foreign Medical Graduates (ECFMG) (2018). Mayo Clinic Quality Fellow Certification (2019). Medical Genetics Certificate – Recanti Genetic Institute (2015). Advanced Electrophysiology Certification – Board-Licensed Electromyography (2019).

🏆 Honors & Awards

Summa Cum Laude – University Medical School of Hungary.  Cum Laude – Hassaf Harofeh Medical Center Internship.Israel Medical Association Fellowship Award (2017). Best Abstract Award – American Academy of Neurology (2019).

🔬 Patents & Innovations

Digital Drug Amplifier – Combines digital therapeutics with pharmaceuticals (FDA-approved). IMNM Muscle Disease Screening Software – Released for public use in the USA (2020).

🌐 Professional Memberships

American Neurological Association.Israeli Neuromuscular Society.American Association of Neuromuscular & Electrodiagnostic Medicine

📚 Publications

  • Prolactin and autoimmunity
    Authors: S Shelly, M Boaz, H Orbach
    Year: 2012

 

  • Autonomic dysfunction following COVID-19 infection: an early experience
    Authors: K Shouman, G Vanichkachorn, WP Cheshire, MD Suarez, S Shelly, et al.
    Year: 2021

 

  • Thymoma and autoimmunity
    Authors: S Shelly, N Agmon-Levin, A Altman, Y Shoenfeld
    Year: 2011

 

  • Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy
    Authors: S Shelly, JD Triplett, MV Pinto, M Milone, FE Diehn, A Zekeridou, et al.
    Year: 2020

 

  • Epidemiology and natural history of inclusion body myositis: a 40-year population-based study
    Authors: S Shelly, MM Mielke, J Mandrekar, M Milone, FC Ernste, E Naddaf, et al.
    Year: 2021

 

  • Survival and associated comorbidities in inclusion body myositis
    Authors: E Naddaf, S Shelly, J Mandrekar, AM Chamberlain, EM Hoffman, et al.
    Year: 2022

 

  • Small fiber neuropathy incidence, prevalence, longitudinal impairments, and disability
    Authors: SA Johnson, K Shouman, S Shelly, P Sandroni, SE Berini, PJB Dyck, et al.
    Year: 2021

 

  • Neurochondrin neurological autoimmunity
    Authors: S Shelly, TJ Kryzer, L Komorowski, R Miske, MD Anderson, EP Flanagan, et al.
    Year: 2019

 

  • Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study
    Authors: S Shelly, SL Zaltsman, O Ben-Gal, A Dayan, I Ganmore, C Shemesh, et al.
    Year: 2021

 

  • Neurofascin-155 immunoglobulin subtypes: clinicopathologic associations and neurologic outcomes
    Authors: S Shelly, CJ Klein, PJB Dyck, P Paul, ML Mauermann, SE Berini, B Howe, et al.
    Year: 2021

 

Conclusion

Dr. Shahar Shelly exemplifies excellence in clinical practice, academic leadership, and innovative research. His focus on using cutting-edge technologies like AI and biomarker discovery aims to transform the diagnosis and treatment of complex neurological and neuromuscular disorders. Driven by a commitment to precision medicine, his career reflects a blend of academic rigor, clinical expertise, and groundbreaking contributions that continue to shape the future of neurology.